PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Aluminium Chloride→

Aluminium Chloride PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
7446-70-0
Molecular formula
AlCl3
Molecular weight
133.34 g/mol
Drug class
Topical antiperspirant and astringentinorganic aluminium salt
Mechanism of action
Aluminium chloride reacts with components of sweat and proteins within the eccrine sweat duct, producing temporary ductal obstruction and reducing sweat reaching the skin surface. This is a local physical/chemical effect rather than systemic pharmacology.
Indications / reported uses
  • Topical treatment of primary focal hyperhidrosis, particularly axillary, palmar and plantar excessive sweating, using the product-specific concentration and application schedule

Sources: NHS — Hyperhidrosis treatment · British Association of Dermatologists — Hyperhidrosis patient information · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Aluminium Chloride PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Aluminium Chloride Permitted Daily Exposure (PDE) report (the Aluminium Chloride PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Aluminium Chloride Occupational Exposure Limit (OEL) report (the Aluminium Chloride OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.